Stocks Hitting 52-Week Lows

shares touched a new 52-week low of $4.27. Vitae Pharmaceuticals reported a Q4 loss $0.52 per share on revenue of $92,000. Stifel Nicolaus downgraded Vitae Pharmaceuticals from Buy to Hold.

shares touched a new 52-week low of $8.99. Tuniu shares have declined 26.60 percent over the past 52 weeks, while the S&P 500 index has dropped 3.76 percent in the same period.

shares fell 15.29 percent to reach a new 52-week low of $27.87 as the company reported a wider-than-expected loss for its fiscal third quarter on Thursday.

shares fell 2.95 percent to touch a new 52-week low of $9.20. Fibria Celulose shares have tumbled 26.91 percent over the past 52 weeks, while the S&P 500 index has dropped 3.76 percent in the same period.